Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproic Acid + FEC100 in locally advanced or metastatic breast cancer
NCT01010854Phase 2Terminated
- Sponsor
- University of California, San Francisco
- Start
- Dec 2008
- Primary completion
- Dec 2010
- Countries
- 1
01
Overview
A Phase 2 trial of valproic acid in breast cancer, sponsored by University of California, San Francisco. Started Dec 2008; status: terminated.
02
Drugs
valproic acid
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01010854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01010854.